Helus Pharma Inc. (HELP) Form 6-K — Oct 8, 2026
Helus Pharma Inc. (Nasdaq: HELP, Cboe CA: HELP) announced it will host an investor presentation on October 21, 2026 at 9:00 a.m. EDT, with a live webcast and archived replay available on its website. The presentation will cover HLP003, the company's proprietary novel serotonergic agonist in Phase 3 development for adjunctive treatment of major depressive disorder with FDA Breakthrough Therapy Designation, and HLP004, its Phase 2 candidate for generalized anxiety disorder.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.